Azithromycin News and Research

RSS
Azithromycin, also known as Zithromax, belongs to the class of medicines known as antibacterials orantibiotics. These medicines kill bacteria (small organisms that can cause infection in humans) or stopbacteria from growing. Patients with weakened immune systems, includingpeople with HIV, tend to have more frequent andmore serious bacterial infections. Azithromycinwas approved by the FDA on June 14, 1996, formany uses, including the prevention and treatmentof Mycobacterium avium complex (MAC) inpersons with advanced HIV infection. It is alsobeing investigated to see how well it works inpreventing other kinds of bacterial infections inpeople with HIV.
Discovery of better treatment for bacterial pneumonia

Discovery of better treatment for bacterial pneumonia

Chlamydia treatment in UK pharmacies will deliver convenient care for patients

Chlamydia treatment in UK pharmacies will deliver convenient care for patients

Chlamydia antibiotic available over-the-counter in the UK

Chlamydia antibiotic available over-the-counter in the UK

New understanding of how some bacteria survive antibiotic treatment

New understanding of how some bacteria survive antibiotic treatment

Rethink needed on how communities affected with trachoma are treated

Rethink needed on how communities affected with trachoma are treated

Biannual mass antibiotic treatment may help reduce contagious eye disease trachoma in Africa

Biannual mass antibiotic treatment may help reduce contagious eye disease trachoma in Africa

Mylan receives FDA approval for Azithromycin tablets

Mylan receives FDA approval for Azithromycin tablets

Simple "dipstick" test could save millions from blindness

Simple "dipstick" test could save millions from blindness

Single dose of oral antibiotic azithromycin taken after trichiasis eye surgery prevents recurrence of inturned eyelashes

Single dose of oral antibiotic azithromycin taken after trichiasis eye surgery prevents recurrence of inturned eyelashes

Antibiotic not sufficient for treating trachoma in populations with high disease prevalence

Antibiotic not sufficient for treating trachoma in populations with high disease prevalence

Risk factors for nongonococcal urethritis

Risk factors for nongonococcal urethritis

Tropical diseases such as sleeping sickness, schistosomiasis, river blindness, hookworm, elephantiasis, and blinding trachoma are being ignored

Tropical diseases such as sleeping sickness, schistosomiasis, river blindness, hookworm, elephantiasis, and blinding trachoma are being ignored

Using X-ray crystallography, researchers have "seen" the structural basis for antibiotic resistanc

Using X-ray crystallography, researchers have "seen" the structural basis for antibiotic resistanc

Researchers make gains in understanding antibiotic resistance

Researchers make gains in understanding antibiotic resistance

Antibiotic treatment does not reduce risk of secondary cardiac events

Antibiotic treatment does not reduce risk of secondary cardiac events

Invasive pneumonia and antibiotic resistance decreased after childhood streptococcus pneumoniae vaccine introduced

Invasive pneumonia and antibiotic resistance decreased after childhood streptococcus pneumoniae vaccine introduced

Immediate access to antibiotics stems spread of sexually transmitted diseases

Immediate access to antibiotics stems spread of sexually transmitted diseases

Study highlights the effectiveness of azithromycin (Zithromax) in reducing infection rates of trachoma

Study highlights the effectiveness of azithromycin (Zithromax) in reducing infection rates of trachoma

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections